Dr. Linda Awdishu, Pharm.D., MAS
Professor of Clinical Pharmacy
Head, Division of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Pronouns: She|Her|Hers
My research program is centered around the pharmacokinetics and dosing of drugs in kidney diseases, estimation of kidney function and drug dosing implications, and the clinical phenotyping, epidemiology, and biomarkers of drug-induced kidney injury. As an academic pharmacist specialized and practicing in nephrology, my aim is to enhance the scientific research around drug exposure and toxicity as it relates to kidney diseases. I am a co-investigator in Core A (Resource for Clinical Studies of AKI) of the NIH-funded UAB-UCSD O’Brien Center for Acute Kidney Injury Research. In this role, I have developed registry studies of acute kidney injury (AKI), conducted research on novel biomarkers of AKI in various sub-populations and developed an international consortium of collaborators investigating the pharmacogenomics of drug-induced kidney injury (DIRECT Study).
Education: B.S. in Pharmacy (1999) University of Toronto; Pharm.D. (2008) University of Colorado; Masters of Advanced Studies in Clinical Research (2007) University of California, San Diego. San Diego. Healthcare Leadership Academy (2017) University of California, San Diego
Awards and Honors: UCSD Health Sciences Department/Division Excellence in Mentoring Award Honoree: “Division of Clinical Pharmacy”, Skaggs School of Pharmacy and Pharmaceutical Sciences. Linda Awdishu (Division Head), Jennifer Le, Joseph Ma, Candis Morello, Shirley Tsunoda – Faculty Mentor Training Directors. (2024); Preceptor of the Year Award, UCSD Pharmacy Practice Residency Program (2024); Excellence in Clinical Services, UCSD SSPPS (2024); Preceptor Excellence Award, UCSD SSPPS (2023); UCSD Inclusive Excellence Award Recipient for Academic Affairs (2023); Teacher of the Year, UC San Diego School of Pharmacy (2022); Fellow of American Society of Nephrology (2022); Elected as Nephrology Board Member, American Board of Internal Medicine, 2019-2022; Invited to serve on American Society of Nephrology Programming Committee, 2018-2020; Teacher of the Year, UC San Diego School of Pharmacy (2016); Award for Excellence in Medication Use Safety, American Society of Health Systems Pharmacists Foundation (2014); Barbara and Paul Saltman Distinguished Teaching Award, UC San Diego Academic Senate (2015); Teacher of the Year, UC San Diego School of Pharmacy (2012); Apples for Preceptors Award, UCSF School of Pharmacy (2008); Preceptor of the Year Award, UCSD Pharmacy Practice Residency Program (2007); San Diego Preceptor of the Year Award, UCSF School of Pharmacy (2006); Canadian Society of Hospital Pharmacy National Schering Award for Pharmacokinetics (2003); Canadian Society of Hospital Pharmacy, Ontario Branch Douglas J Stewart Award for Hospital Administrators (2002).
Leadership Experience: Division Head, Clinical Pharmacy
- Therapeutics and Advanced Professional Practice 213 series
- APPE Preceptor for Ambulatory Care Chronic Kidney Disease and Solid Organ Transplant
- Pharmacy residency preceptor for longitudinal ambulatory care clinic rotation
- P3 Objective Structured Clinical Experiences
- P2 and P3 Inter-professional Education Experiences
- Masters for Advanced Studies in Clinical Research: Faculty Mentor, Research Mentor
- Development of new clinical faculty practice sites at affiliate health systems.
- Excellence in faculty mentorship, development and academic advancement.
- Developed institutional Pharmacy and Therapeutics Protocols for Prescribing in Renal Disease as well as electronic algorithms for renal dosage adjustments.
- Implemented electronic GFR reporting at the clinical laboratories for UCSD Medical Center.
- Developed and lead the multidisciplinary Chronic Kidney Disease Program at UC San Diego Health System. http://health.ucsd.edu/specialties/nephrology/Pages/chronic-kidney-disease.aspx
- Project leader for the development of patient education videos for the Chronic Kidney Disease Program: https://www.youtube.com/channel/UCOaegTYfii7Gl9ytqZa8i_Q
- Developed clinical pharmacy transplant services at UCSD Medical Center.
- Clinical research in chronic kidney disease and acute kidney injury in the ambulatory and hospitalized patient populations.
- (November 2024) W. L. St Peter, A. Bzowyckyj, T. Anderson-Haag, L. Awdishu, M. Blackman, A. Bland, E. Chan, C. Chmielewski, C. Delgado, R. Eyler, C. Foster, J. Hudson, S. L. Kane-Gill, M.A. Kliethermes, T. Le, R. Madabushi, B. Martin, W.G. Miller, J. J. Neumiller, A. M. Philbrick, G. Roberts, V. Schandorf, A. J. Webb, D. Wu, T. D. Nolin; Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions - PubMed
- (November 2024) C. M. Morello 1 2, L. Awdishu, S. Lam, A. Heman, M. Bounthavong Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes - PubMed Development and validation of a deep learning algorithm for the prediction of serum creatinine in critically ill patients - PubMed (September 2024)
- (October 2024) R. A. Rodriguez, M. A. Sparks, P. T. Conway, A. Gavhane, S. Reddy, L. Awdishu, S. Waheed, S. Davidson, D. B. Adey, J.P. Lea, J. C. Lieske, F. S. McDonald American Board of Internal Medicine Nephrology Procedure Requirements for Initial Certification: Time for a Change and Pursuing Consensus in the Nephrology Community - PubMed
- (August 2024) M. Ostermann, L. Awdishu, M. Legrand 3 Using diuretic therapy in the critically ill patient - PubMed
- (December 2023) M. Henderson, L. Awdishu, G. P. Morris, K. Fabbri, M. Shah, A. Khan, J. Kerr Subtle Changes in Tacrolimus Levels Have an Impact on Early Donor-Specific Antibodies in Kidney Transplantation - PubMed
- (December 2023) A. a. Feist, M. Mariski, L. Awdishu, M. Bremer, G. Yung, C. Jung, E. Golts, K. afshar 5 Sirolimus Long-Term Tolerability and Impact on Kidney Function in Lung Transplantation: A Single-Center Experience - PubMed
- (November 2023) I. Karimzadeh, E.F. Barreto, J. A. Kellum, L. Awdishu, P. T. Murray, M. Ostermann, A. Bihorac, R. L. Mehta, S. L. Goldstein, K. B. Kashani, S. L. Kane-Gil Moving toward a contemporary classification of drug-induced kidney disease - PubMed
- (October 2023) C. L. Mnatzaganian, R. F. Singh, K. Brandl, J. M. Namba, L. A. Hart, M. Bounthavong, C. M. Morello, L. Awdishu, A. J. Luli, K. C. Lee, N. Patel Influence of the number, timing, and types of advanced pharmacy practice experiences on residency matching - PubMed
- (August 2023) K. B. Kashani, L. Awdishu, S. M. Bagshaw, E. F. Barreto, R. Claure-Del Granado, B. J. Evans, L. G. Forni, E. Ghosh, S. L. Goldstein, S. L. Kane-Gill, J. Koola, J. L. Koyner, M. Liu, R. Murugan, G. N. Nadkarni, J. A. Neyra, J. Ninan, M. Ostermann, N. Pannu, P. Rashidi, C. Ronco, M. H. Rosner, N. M. Selby, B. Shickel. K. Singh. D. E. Soranno, S> M. Sutherland, A. Bihorac, R. L. Mehta Digital health and acute kidney injury: consensus report of the 27th Acute Disease Quality Initiative workgroup - PubMed
- Pharmacogenomic studies of drug induced nephrotoxicity.
- Pharmacokinetic studies in kidney disease and transplantation